Sat.Aug 17, 2024 - Fri.Aug 23, 2024

article thumbnail

Majority of Savings from CMS Price Negotiations Comes From 3 Drugs

Drug Topics

Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.

281
281
article thumbnail

BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings

PharmaVoice

With fewer side effects, the new wave of upcoming drugs could improve patient adherence, and the competition for a large projected market is getting fierce.

290
290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

Pharmacy Times

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

FDA 149
article thumbnail

Merck Ebola vaccine Ervebo shown to offer substantial protection

STAT

Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had been vaccinated at least 10 days before being exposed to the virus, a new study reports. An earlier study had shown that people who were vaccinated but went on to develop the disease were more likely to survive the infection.

Vaccines 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

APhA Campaign Aims to Spread Awareness About Harmful PBM Practices

Drug Topics

The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.

551
551
article thumbnail

23andMe inches closes to cancer immunotherapy, guided by its genetic database

PharmaVoice

Dr. Jennifer Low, head of 23andMe’s therapeutics division, is taking the company into new territory with a potential cancer treatment that targets a unique pathway.

235
235

More Trending

article thumbnail

Opinion: Why you may not need a checkup every year

STAT

I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.

145
145
article thumbnail

Meat Consumption Linked with Higher Risk of Developing Type 2 Diabetes

Drug Topics

Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.

498
498
article thumbnail

Epic touts new AI applications to streamline charting and bring research insights to the point of care

Fierce Healthcare

Health IT giant Epic is pushing ahead rapidly to build out artificial intelligence technologies and generative AI features in its electronic health record software. | The goal, according to Epic executives, is to ease the documentation burden for clinicians, streamline charting and coding and bring evidence-based medical insights and research right to doctors' fingertips at the point of care.

article thumbnail

Expert: Diabetes Initiatives Led by Community Pharmacists, Students Drive Treatment Innovation

Pharmacy Times

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Long Covid symptoms in kids aren’t one-size-fits-all, study shows

STAT

Rachel Gross wants to clear up misconceptions about children and Covid-19. A pediatrician and population health researcher, she recalls a time four years ago when people didn’t think children could even contract the disease. Then, after accepting kids’ vulnerability to the virus, it was thought only adults could suffer from the myriad symptoms that persist or crop up post-infection, collectively known as long Covid.

29
article thumbnail

A Diabetes Intervention in Community Pharmacy Drives Value-Based Health Care

Drug Topics

A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.

article thumbnail

Bayer layoffs hit Switzerland with 150 cuts at Basel consumer health hub: reports

Fierce Pharma

Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.

143
143
article thumbnail

Analysis Finds Bidirectional Association Between Asthma and Psoriasis

Pharmacy Times

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

145
145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it

STAT

Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer. She and her husband, Ben Burnham, were devastated, physically and financially drained — and deeply frustrated by the lack of answers or support for people like them who had experienced recurrent miscarriages.

29
article thumbnail

Pharmacy Deserts Prominent in Areas of High Social Vulnerability

Drug Topics

Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.

469
469
article thumbnail

New study suggesting suicidal ideation risk for Novo's Ozempic adds to ongoing safety debate

Fierce Pharma

Regulators in both the U.S. and Europe have looked into the potential link between suicidal thoughts and Novo Nordisk’s blockbuster semaglutide franchise after reports sounded the alarm last year. | Researchers found that users of Novo's semaglutide who were logged in a WHO database were more likely to report suicidal ideation.

140
140
article thumbnail

Food As Medicine Can Change Patient Lives, But Establishing Models, Payment Pathways Is Critical

Pharmacy Times

New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.

145
145
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Lilly’s Zepbound slashed risk of developing diabetes

STAT

Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In a Phase 3 trial that lasted over three years, people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to diabetes compared with people on placebo, Lilly said Tuesday.

145
145
article thumbnail

Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study

Drug Topics

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

407
407
article thumbnail

Industry Voices—10 things every healthcare organization can do to defend against cyberattacks

Fierce Healthcare

The healthcare industry confronts a complex, double-barreled challenge as it tries to combat the recent deluge of dangerous and damaging cyberattacks. | Cyber resilience is the ability to recognize threats, respond to them, recover quickly and at scale. The clear goal: fending off attacks more efficiently, limiting damage and restoring normal operations with minimal impact to patients.

138
138
article thumbnail

Expert: Emphasis on Diabetes Research Can Close Gaps in Marginalized Communities

Pharmacy Times

Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.

139
139
article thumbnail

Opinion: Private equity: health care’s vampire

STAT

Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.

article thumbnail

Q&A: Discussing the Dangers of Buying GLP-1s From Online Pharmacies

Drug Topics

Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.

407
407
article thumbnail

Lawmakers urge FDA to investigate clinical trials run in tandem with China's military

Fierce Pharma

As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem. | As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem.

FDA 135
article thumbnail

Highlight: How The NACDS Foundation Promotes Research, Change in Pharmacy

Pharmacy Times

Sara Roszak discusses her role as president of the NACDS Foundation.

139
139
article thumbnail

STAT+: Peter Orszag wants the FTC and DOJ to stop challenging health care mergers

STAT

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank. Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create.

Insurance 145
article thumbnail

COVID-19: FDA Approves, Grants EUA to Moderna, Pfizer 2024-2025 Vaccine Formulations

Drug Topics

Novavax is still awaiting FDA authorization for their protein-based COVID-19 vaccine.

Vaccines 387
article thumbnail

US govt taps Walgreens for decentralised trials

pharmaphorum

Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network

134
134
article thumbnail

NACDS President Discusses Themes, Highlights of Total Store Expo

Pharmacy Times

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

139
139
article thumbnail

FDA approves updated Covid-19 vaccines, shots should be available in days

STAT

WASHINGTON — U.S. regulators approved  updated Covid-19 vaccines  on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.

Vaccines 145
article thumbnail

Q&A: NACDS President and CEO on PBM Reform and Grassroots Advocacy

Drug Topics

The National Association of Chain Drug Stores is active at both the federal and state levels in advocating for PBM reform.

387
387
article thumbnail

Employers embracing direct contracting and bypassing insurers: survey

Fierce Healthcare

Employers are actively seeking out alternatives to curb rising health benefit costs by sidestepping traditional carriers, a new report from Brighton Health Plan Solutions shows. | A new report highlights a business opportunity for providers and health systems to engage in direct contracting.

Insurance 133